Hint mode is switched on Switch off

Corvus Pharmaceuticals, ordinary share
CRVS, US2210151005

Add a stock to WL
Choose all Reset all
Corvus Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    Corvus Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRVS
  • Placement
    23.03.2016
  • Lock up period
    180
  • Number of papers
    4,700,000
  • Volume of raised funds
    70.5 mln USD
  • Final placement price
    15 USD
  • Price change since placement date
    -25.67%
  • By capitalization
    306.1 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRVS
  • Placement
    07.03.2018
  • Lock up period
    180
  • Number of papers
    5,530,973
  • Volume of raised funds
    50 mln USD
  • Placement share
    20.81%
  • Final placement price
    9.04 USD
  • Price change since placement date
    23.34%
  • By capitalization
    240.21 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRVS
  • Placement
    12.02.2021
  • Lock up period
    180
  • Number of papers
    8,571,429
  • Volume of raised funds
    30 mln USD
  • Placement share
    23.4%
  • Final placement price
    3.5 USD
  • Price change since placement date
    218.57%
  • By capitalization
    128.21 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRVS
  • Placement
    03.05.2024
  • Lock up period
    180
  • Number of papers
    13,512,699
  • Volume of raised funds
    23.38 mln USD
  • Placement share
    20.26%
  • Final placement price
    1.73 USD
  • Price change since placement date
    544.06%
  • By capitalization
    115.46 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CRVS
  • Placement
    23.01.2026
  • Lock up period
    180
  • Number of papers
    7,900,677
  • Volume of raised funds
    175 mln USD
  • Placement share
    9.57%
  • Final placement price
    22.15 USD
  • Price change since placement date
    -49.66%
  • By capitalization
    1,829.2 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

13/03/2026 Corvus Pharmaceuticals: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
29/01/2026 Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Sees Significant Price Target Increase and Stock Surge
21/01/2026 Corvus Pharmaceuticals (NASDAQ:CRVS) Sees Promising Advancements in Eczema Treatment
21/01/2026 Corvus Pharmaceuticals: Other Events, Financial Statements And Exhibits
02/10/2025 Corvus Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
All organization news

Holders

Industry Leaders

Registration is required to get access.